Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07199374

PARCA (a Digital Tool) to Improve Justice and Health

The purpose of this study is to assess the effectiveness of the Probation/Parole and Reentry Coach Application (PARCA)-a mobile application that allows justice-involved people to set and manage personal goals to support sustained, successful community supervision. Through this study, we aim to conduct surveys and interviews aimed to gain a better understanding of ways to improve the substance use treatment process, connections between clients and officers, and goal selection and achievement for clients using the PARCA app

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Behavioral Addiction

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Travis County Community Services, Austin, Texas, United States

Loading trial locations.

About this study

This study tests a new technological intervention referred to as Probation/Parole and Reentry Coach Application (PARCA). The application uses motivational interviewing and cognitive behavioral techniques to engage clients in problem solving by identifying issues, identifying goals, making progress towards the goals, incentivizing clients to achieve the goals, and working towards completion of supervision. Officers can view the goals, progress, and points accumulated to improve supervision outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All officers that supervise individuals All individuals on supervision that indicate drug use -

Exclusion criteria

Individuals that have poor performance on their job clients have serious mental health disorders

-

Treatment and study plan

PARCA

Behavioral

PARCA is an s an app to facilitate goal management, resource allocation, and managing progress.

Primary outcomes

  1. Number of Days till the Individual Initiates Treatment

    Time frame: The timeframe is 365 days

    This represents the number of days that the individual starts treatment based on the day that they started supervision. This can be measured in the supervision records. This is an event in the record system like an electronic health record.

Secondary outcomes

  1. Number of Treatment Sessions in 90 days

    Time frame: For 365 days

    This represents the number of times the individual participated in treatment during a 90 day window. This can be measured from supervision records.

Other outcomes

  1. Drug Tests

    Time frame: through study completion, an average of 1 year

    Test positive for an illicit drug

  2. Number of times the individual has been arrested or technically violated probation

    Time frame: This is for 365 days

    This criminal justice outcome refers to other criminal behavior and/or failure to abide by supervision conditions. Both reflect events that can be measured in the supervision records.

Study contacts

Contact information is provided by the study sponsor or research team.

Faye S Taxman, Ph.D.

CONTACT

[email protected]

7039938555

Sponsors and collaborators

Lead sponsor

George Mason University

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)
  • Q2i, LLC
  • RTI International
  • Worcester Polytechnic Institute

Registry information

Acronym: Parca

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Sep 30, 2025
Registry last updated
Sep 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.